dm+d

Unassigned

New Medicines

Newly diagnosed glioblastoma - combination therapy

Information

New molecular entity
Celgene
Celgene

Development and Regulatory status

Phase III Clinical Trials
Phase III Clinical Trials
Phase III Clinical Trials

Category

Proteasome inhibitor
In England and Wales, about 1,860 gliomas are diagnosed each year, of which 740 to 840 are glioblastoma multiform (grade 4 glioma). Median survival is 11 mtgs [2].
Newly diagnosed glioblastoma - combination therapy
Intravenous